Published in J Urol on January 01, 2003
Tissue-engineered autologous urethras for patients who need reconstruction: an observational study. Lancet (2011) 3.95
Cell responses to the mechanochemical microenvironment--implications for regenerative medicine and drug delivery. Adv Drug Deliv Rev (2007) 1.94
Cell-seeded tubularized scaffolds for reconstruction of long urethral defects: a preclinical study. Eur Urol (2012) 1.69
Small intestinal submucosa for vascular reconstruction in the presence of gastrointestinal contamination. Ann Surg (2004) 1.02
Tissue engineering: current strategies and future directions. Chonnam Med J (2011) 0.96
Regenerative medicine as applied to general surgery. Ann Surg (2012) 0.92
Concentrated collagen-chondroitin sulfate scaffolds for tissue engineering applications. J Biomed Mater Res A (2010) 0.88
Tissue engineering for human urethral reconstruction: systematic review of recent literature. PLoS One (2015) 0.85
Tissue engineering of the penis. ScientificWorldJournal (2011) 0.83
Management of the stricture of fossa navicularis and pendulous urethral strictures. Indian J Urol (2011) 0.83
A collagen matrix derived from bladder can be used to engineer smooth muscle tissue. World J Urol (2008) 0.81
Acellular bi-layer silk fibroin scaffolds support tissue regeneration in a rabbit model of onlay urethroplasty. PLoS One (2014) 0.81
Tissue engineering of urinary bladder and urethra: advances from bench to patients. ScientificWorldJournal (2013) 0.80
[Reconstructive urology in transition. From its origin into the all too near future]. Urologe A (2006) 0.79
Urethroplasty using autologous urethral tissue-embedded acellular porcine bladder submucosa matrix grafts for the management of long-segment urethral stricture in a rabbit model. J Korean Med Sci (2015) 0.78
In vivo magnetic resonance imaging of type I collagen scaffold in rat: improving visualization of bladder and subcutaneous implants. Tissue Eng Part C Methods (2014) 0.76
Tissue engineering in urology. Can Urol Assoc J (2009) 0.76
Spatial patterning of endothelial cells and vascular network formation using ultrasound standing wave fields. J Acoust Soc Am (2013) 0.75
Cell-seeded tubular acellular matrix for replacing a long circumferential urethral defect in a canine model: Is it clinically applicable? Arab J Urol (2012) 0.75
Applications of regenerative medicine in organ transplantation. J Pharm Bioallied Sci (2015) 0.75
The potential role of regenerative medicine in the man-agement of traumatic patients. J Inj Violence Res (2014) 0.75
Seeding cell approach for tissue-engineered urethral reconstruction in animal study: A systematic review and meta-analysis. Exp Biol Med (Maywood) (2016) 0.75
Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol (2007) 9.67
Tissue-engineered autologous bladders for patients needing cystoplasty. Lancet (2006) 7.64
Tissue-engineered autologous urethras for patients who need reconstruction: an observational study. Lancet (2011) 3.95
Nomograms for predicting annual resolution rate of primary vesicoureteral reflux: results from 2,462 children. J Urol (2009) 2.59
Engineering complex tissues. Tissue Eng (2006) 2.53
Derivation and comparative assessment of retinal pigment epithelium from human embryonic stem cells using transcriptomics. Cloning Stem Cells (2004) 2.32
Contemporary epidemiology and characterization of newborn males with prune belly syndrome. Urology (2010) 2.30
Carbon nanotube applications for tissue engineering. Biomaterials (2006) 2.25
Anterior urethral valves and diverticula in children: a result of ruptured Cowper's duct cyst? BJU Int (2004) 2.19
Gender assignment for newborns with 46XY cloacal exstrophy: a 6-year followup survey of pediatric urologists. J Urol (2011) 2.11
The use of whole organ decellularization for the generation of a vascularized liver organoid. Hepatology (2011) 2.09
Management of recurrent urethral strictures after hypospadias repair: is there a role for repeat dilation or endoscopic incision? J Pediatr Urol (2010) 2.03
Human amniotic fluid-derived stem cells are rejected after transplantation in the myocardium of normal, ischemic, immuno-suppressed or immuno-deficient rat. J Mol Cell Cardiol (2006) 1.99
Generation of histocompatible tissues using nuclear transplantation. Nat Biotechnol (2002) 1.97
Antiangiogenic properties of gold nanoparticles. Clin Cancer Res (2005) 1.78
Controlled fabrication of a biological vascular substitute. Biomaterials (2005) 1.76
Long-term experience and outcomes of robotic assisted laparoscopic pyeloplasty in children and young adults. J Urol (2011) 1.76
Cell-seeded tubularized scaffolds for reconstruction of long urethral defects: a preclinical study. Eur Urol (2012) 1.69
Tissue engineering, stem cells, and cloning: opportunities for regenerative medicine. J Am Soc Nephrol (2004) 1.68
Fibroepithelial polyps causing ureteropelvic junction obstruction in children. J Urol (2003) 1.63
Prepubertal testis tumors: actual prevalence rate of histological types. J Urol (2004) 1.61
Robotic assisted laparoscopic Mitrofanoff appendicovesicostomy: preliminary experience in a pediatric population. J Urol (2009) 1.59
Robotic assisted laparoscopic ureteral reimplantation in children: case matched comparative study with open surgical approach. J Urol (2011) 1.58
Implantation of autologous urine derived stem cells expressing vascular endothelial growth factor for potential use in genitourinary reconstruction. J Urol (2011) 1.56
Decellularization methods of porcine kidneys for whole organ engineering using a high-throughput system. Biomaterials (2012) 1.55
Urine derived cells are a potential source for urological tissue reconstruction. J Urol (2008) 1.54
Bladder neck reconstruction is often necessary after complete primary repair of exstrophy. J Urol (2011) 1.53
Bioengineered vascular access maintains structural integrity in response to arteriovenous flow and repeated needle puncture. J Vasc Surg (2012) 1.52
Long-term incidence of urinary tract infection after ureteral reimplantation for primary vesicoureteral reflux. J Pediatr Urol (2012) 1.48
Analysis of indications for ureteral reimplantation in 3738 children with vesicoureteral reflux: a single institutional cohort. J Pediatr Urol (2011) 1.48
The influence of electrospun aligned poly(epsilon-caprolactone)/collagen nanofiber meshes on the formation of self-aligned skeletal muscle myotubes. Biomaterials (2008) 1.47
Whole organ decellularization - a tool for bioscaffold fabrication and organ bioengineering. Conf Proc IEEE Eng Med Biol Soc (2009) 1.47
Pediatric robot assisted laparoscopic dismembered pyeloplasty: comparison with a cohort of open surgery. J Urol (2006) 1.47
The in vivo stability of electrospun polycaprolactone-collagen scaffolds in vascular reconstruction. Biomaterials (2008) 1.46
Human amniotic fluid stem cells can integrate and differentiate into epithelial lung lineages. Stem Cells (2008) 1.46
Multipotential differentiation of human urine-derived stem cells: potential for therapeutic applications in urology. Stem Cells (2013) 1.46
Engineered multilayer ovarian tissue that secretes sex steroids and peptide hormones in response to gonadotropins. Biomaterials (2012) 1.45
Randomized comparative study between buccal mucosal and acellular bladder matrix grafts in complex anterior urethral strictures. J Urol (2008) 1.45
Production and implantation of renal extracellular matrix scaffolds from porcine kidneys as a platform for renal bioengineering investigations. Ann Surg (2012) 1.45
Risk factors for urinary tract infection after renal transplantation and its impact on graft function in children and young adults. J Urol (2010) 1.45
Perioperative risk factors for surgical complications in pediatric urology: a pilot study in preoperative risk assessment in children. Urology (2009) 1.44
Protective effect of human amniotic fluid stem cells in an immunodeficient mouse model of acute tubular necrosis. PLoS One (2010) 1.44
Chondrogenic differentiation of amniotic fluid-derived stem cells. J Mol Histol (2007) 1.44
Principals of neovascularization for tissue engineering. Mol Aspects Med (2002) 1.44
B7-h1 as a biomarker for therapy failure in patients with favorable histology Wilms tumor. J Urol (2012) 1.43
Development and initial validation of a scoring system to diagnose testicular torsion in children. J Urol (2012) 1.40
Reprogramming of human somatic cells using human and animal oocytes. Cloning Stem Cells (2009) 1.40
Durability of antireflux effect of ureteral reimplantation for primary vesicoureteral reflux: findings on long-term cystography. Urology (2012) 1.39
What is the optimal surgical strategy for bulbous urethral stricture in boys? J Urol (2009) 1.39
Development of a composite vascular scaffolding system that withstands physiological vascular conditions. Biomaterials (2008) 1.35
Hybrid printing of mechanically and biologically improved constructs for cartilage tissue engineering applications. Biofabrication (2012) 1.34
Regenerative medicine as applied to solid organ transplantation: current status and future challenges. Transpl Int (2010) 1.33
Stretch and growth: the molecular and physiologic influences of tissue expansion. Plast Reconstr Surg (2002) 1.30
Human urine-derived stem cells seeded in a modified 3D porous small intestinal submucosa scaffold for urethral tissue engineering. Biomaterials (2010) 1.30
Amniotic fluid and placental stem cells. Methods Enzymol (2006) 1.30
Bilayered scaffold for engineering cellularized blood vessels. Biomaterials (2010) 1.29
Mesenchymal stem cells and adipogenesis in hemangioma involution. Stem Cells (2006) 1.25
Adipose tissue engineering for soft tissue regeneration. Tissue Eng Part B Rev (2010) 1.25
Differentiation of human bone marrow mesenchymal stem cells into bladder cells: potential for urological tissue engineering. Tissue Eng Part A (2010) 1.25
Oxygen generating scaffolds for enhancing engineered tissue survival. Biomaterials (2008) 1.24
Urethral replacement using cell seeded tubularized collagen matrices. J Urol (2002) 1.24
Identification and characterization of bioactive factors in bladder submucosa matrix. Biomaterials (2007) 1.24
A rat decellularized small bowel scaffold that preserves villus-crypt architecture for intestinal regeneration. Biomaterials (2012) 1.21
Characterization of urine-derived stem cells obtained from upper urinary tract for use in cell-based urological tissue engineering. Tissue Eng Part A (2011) 1.21
Tissue-specific extracellular matrix coatings for the promotion of cell proliferation and maintenance of cell phenotype. Biomaterials (2009) 1.21
Cell cycle checkpoint function in bladder cancer. J Natl Cancer Inst (2003) 1.21
Complex heterogeneous tissue constructs containing multiple cell types prepared by inkjet printing technology. Biomaterials (2012) 1.21
Tubularized urethral replacement with unseeded matrices: what is the maximum distance for normal tissue regeneration? World J Urol (2008) 1.20
Robot-assisted laparoscopic excision of symptomatic retrovesical cysts in boys and young adults. J Urol (2011) 1.19
Ultrasound versus computerized tomography for evaluating urolithiasis. J Urol (2009) 1.18
Sources of stem cells for regenerative medicine. Stem Cell Rev (2008) 1.17
Prospective followup in patients after complete primary repair of bladder exstrophy. J Urol (2008) 1.17
Oxygen producing biomaterials for tissue regeneration. Biomaterials (2007) 1.16
Myogenic differentiation of human bone marrow mesenchymal stem cells on a 3D nano fibrous scaffold for bladder tissue engineering. Biomaterials (2009) 1.16